PAVM
HEALTHCAREPAVmed Inc
$7.01-1.04 (-12.92%)LIVE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving PAVM Today?
No stock-specific AI insight has been generated for PAVM yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$6.00$23.40
$7.01
Fundamentals
Market Cap$51M
P/E Ratio—
EPS$-5.63
Dividend Yield—
Dividend / Share—
ROE-0.3%
Profit Margin5.7%
Debt / Equity—
Trading
Volume19K
Avg Volume (10D)—
Shares Outstanding7.3M
PAVM News
20 articles- Will PAVmed Inc. (PAVM) Report Negative Earnings Next Week? What You Should KnowYahoo Finance·May 8, 2026
- Alphatec (ATEC) Reports Break-Even Earnings for Q1Yahoo Finance·May 5, 2026
- PAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026Yahoo Finance·May 1, 2026
- Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026Yahoo Finance·Apr 30, 2026
- PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue EstimatesYahoo Finance·Apr 29, 2026
- Why The PAVmed (PAVM) Story Is Shifting After A Major Valuation ResetYahoo Finance·Apr 27, 2026
- Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common StockYahoo Finance·Apr 24, 2026
- Lucid Diagnostics Announces $18 Million Underwritten Offering of Common StockYahoo Finance·Apr 23, 2026
- Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare ConferenceYahoo Finance·Apr 9, 2026
- How The PAVmed (PAVM) Narrative Is Shifting After The Latest Analyst ReassessmentYahoo Finance·Apr 9, 2026
- PAVM Assigns Joseph Virgilio to Lead Medical Device Portfolio RelaunchYahoo Finance·Apr 7, 2026
- PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device PortfolioYahoo Finance·Apr 2, 2026
- PAVmed Inc. Q4 2025 Earnings Call SummaryMoby·Mar 31, 2026
- PAVmed Inc (PAVM) Q4 2025 Earnings Call Highlights: Strategic Restructuring and Growth InitiativesYahoo Finance·Mar 30, 2026
- PAVmed (PAVM) Upgraded to Buy: Here's What You Should KnowYahoo Finance·Mar 30, 2026
- PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial ResultsYahoo Finance·Mar 30, 2026
- Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial ResultsYahoo Finance·Mar 26, 2026
- PAVmed to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 30, 2026Yahoo Finance·Mar 16, 2026
- Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026Yahoo Finance·Mar 12, 2026
- PAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible SecuritiesYahoo Finance·Feb 4, 2026
All 20 articles loaded
Price Data
Open$8.34
Previous Close$8.05
Day High$8.54
Day Low$8.34
52 Week High$23.40
52 Week Low$6.00
52-Week Range
$6.00$23.40
$7.01
Fundamentals
Market Cap$51M
P/E Ratio—
EPS$-5.63
Dividend Yield—
Dividend / Share—
ROE-0.3%
Profit Margin5.7%
Debt / Equity—
Trading
Volume19K
Avg Volume (10D)—
Shares Outstanding7.3M
About PAVmed Inc
PAVmed Inc. is a medical device company in the United States. The company is headquartered in New York, New York.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—